Correlation Between Indaptus Therapeutics and Fresh Tracks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Fresh Tracks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Fresh Tracks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Fresh Tracks Therapeutics, you can compare the effects of market volatilities on Indaptus Therapeutics and Fresh Tracks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Fresh Tracks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Fresh Tracks.

Diversification Opportunities for Indaptus Therapeutics and Fresh Tracks

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Indaptus and Fresh is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Fresh Tracks Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresh Tracks Therapeutics and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Fresh Tracks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresh Tracks Therapeutics has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Fresh Tracks go up and down completely randomly.

Pair Corralation between Indaptus Therapeutics and Fresh Tracks

Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 0.7 times more return on investment than Fresh Tracks. However, Indaptus Therapeutics is 1.43 times less risky than Fresh Tracks. It trades about 0.01 of its potential returns per unit of risk. Fresh Tracks Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  174.00  in Indaptus Therapeutics on September 4, 2024 and sell it today you would lose (74.00) from holding Indaptus Therapeutics or give up 42.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy30.71%
ValuesDaily Returns

Indaptus Therapeutics  vs.  Fresh Tracks Therapeutics

 Performance 
       Timeline  
Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Fresh Tracks Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Indaptus Therapeutics and Fresh Tracks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Indaptus Therapeutics and Fresh Tracks

The main advantage of trading using opposite Indaptus Therapeutics and Fresh Tracks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Fresh Tracks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh Tracks will offset losses from the drop in Fresh Tracks' long position.
The idea behind Indaptus Therapeutics and Fresh Tracks Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance